Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mayo Clinic researchers discover new immune system molecule that can help or harm health

18.06.2003


Mayo Clinic researchers have identified a new member of the important B7 family of immune system "co-stimulators." Co-stimulators are molecules that are capable of turning the immune system on or off -- and in the process, profoundly affecting human health.



Mayo Clinic researchers named this newest molecule B7-H4. It inhibits the action of T cells, the immune system warriors whose basic job is to attack invaders. Turning off T cells helps transplant patients accept foreign organs. But turning off T cells harms cancer patients -- their tumors continue to grow without defensive attacks by T cells. The Mayo Clinic report appears in the June 17 issue of Immunity.

These findings may help researchers learn how to manipulate immune system co-stimulators to serve such therapeutic objectives as:


1) stopping the body from attacking itself in autoimmune diseases;
2) thwarting rejection of transplanted organs;
3) guiding the body to attack a cancer cell.

Significance of the Mayo Clinic Investigation

B7-H4 is the fourth in a line of so-called "co-stimulation" molecules discovered over five years of research led by Lieping Chen, M.D., Ph.D., professor of Immunology at Mayo Medical School. The first in the line, B7-H1, was discovered in 1999 by Dr. Chen and colleagues. And, as in so many families, the members of this molecule family bear intriguing differences. Chief among these differences: Not all B7 members serve the body the same way -- some boost the immune system, some blunt its effect and some do both, at different times, depending on the partner to which they bind and the pathways for action they create.

Says Dr. Chen, "The immune system is a double-edged sword. It can help and it can damage. It has a positive and a negative capacity -- and understanding and controlling these is the key issue for manipulation of diseases with new treatments. This molecule is very important for doing that work because it is a very potent negative regulation component of the immune system."

The Investigation

To examine the B7 group further, Mayo Clinic researchers analyzed genes in a database composed of members that were likely to be part of the B7 superfamily. Then they cloned the B7-H4 molecule, modeled it in 3-D on a computer and found the functional part of interest. Next, they engineered the molecule and tested its effects in T cells, both in cell culture and in live mice. They did this because Dr. Chen’s laboratory is probing the molecular basis of cellular communication to discover how different components of the immune system talk to each other on the cell surface. The basic exchange that occurs on the cell surface involves two parts: a receptor and its partner, which is called a "ligand." How these two parts interact determines the action the immune system takes.

Mayo Clinic’s Findings

B7-H4 is a very powerful "negative regulator," highly efficient at turning off T cells. This is important because in certain diseases, such as cancers, this regulator may be overly active. In healthy cells, there are no negative regulators. The implication: One reason healthy cells are healthy is that they don’t have B7-H4 shutting down the T cells that police the body for invaders; their T cells are working and are protecting them. "In a tumor, you may have excess B7-H4 turning off T cells all the time. In a normal healthy body, the negative regulators like B7-H4 have to be turned on," says Dr. Chen. The mechanism by which B7-H4 inhibits T cells appears to be one of arresting cell division and the cell-proliferation cycle.

At a Glance Summary
  • Some immune system molecules can go both ways: they can have the positive effect of boosting the immune system, or the negative effect of shutting it down -- or do both at different times -- depending on the nature of the partners to which they bind.
  • B7-H4, the subject of Mayo’s current investigation, powerfully shuts down the immune system response of T cells.
  • By discovering which molecules -- and which partners, or ligands -- are involved in turning the immune system on or off, Dr. Chen is confident Mayo Clinic research will help scientists devise new treatment strategies. "This new finding about B7-H4 adds excitement to the possibility of therapeutic manipulation of the immune system," he says.

Mary Lawson | EurekAlert!
Further information:
http://www.mayo.edu/

More articles from Health and Medicine:

nachricht Inselspital: Fewer CT scans needed after cerebral bleeding
20.03.2019 | Universitätsspital Bern

nachricht Building blocks for new medications: the University of Graz is seeking a technology partner
19.03.2019 | Karl-Franzens-Universität Graz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The taming of the light screw

DESY and MPSD scientists create high-order harmonics from solids with controlled polarization states, taking advantage of both crystal symmetry and attosecond electronic dynamics. The newly demonstrated technique might find intriguing applications in petahertz electronics and for spectroscopic studies of novel quantum materials.

The nonlinear process of high-order harmonic generation (HHG) in gases is one of the cornerstones of attosecond science (an attosecond is a billionth of a...

Im Focus: Magnetic micro-boats

Nano- and microtechnology are promising candidates not only for medical applications such as drug delivery but also for the creation of little robots or flexible integrated sensors. Scientists from the Max Planck Institute for Polymer Research (MPI-P) have created magnetic microparticles, with a newly developed method, that could pave the way for building micro-motors or guiding drugs in the human body to a target, like a tumor. The preparation of such structures as well as their remote-control can be regulated using magnetic fields and therefore can find application in an array of domains.

The magnetic properties of a material control how this material responds to the presence of a magnetic field. Iron oxide is the main component of rust but also...

Im Focus: Self-healing coating made of corn starch makes small scratches disappear through heat

Due to the special arrangement of its molecules, a new coating made of corn starch is able to repair small scratches by itself through heat: The cross-linking via ring-shaped molecules makes the material mobile, so that it compensates for the scratches and these disappear again.

Superficial micro-scratches on the car body or on other high-gloss surfaces are harmless, but annoying. Especially in the luxury segment such surfaces are...

Im Focus: Stellar cartography

The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.

A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...

Im Focus: Heading towards a tsunami of light

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.

"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Modelica Conference with 330 visitors from 21 countries at OTH Regensburg

11.03.2019 | Event News

Selection Completed: 580 Young Scientists from 88 Countries at the Lindau Nobel Laureate Meeting

01.03.2019 | Event News

LightMAT 2019 – 3rd International Conference on Light Materials – Science and Technology

28.02.2019 | Event News

 
Latest News

Solving the efficiency of Gram-negative bacteria

22.03.2019 | Life Sciences

Bacteria bide their time when antibiotics attack

22.03.2019 | Life Sciences

Open source software helps researchers extract key insights from huge sensor datasets

22.03.2019 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>